Original articleBrief communicationExternal Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study
Section snippets
Study Population
We analyzed data from the Rotterdam Study, a large, prospective, population-based cohort study conducted among elderly inhabitants of a district of Rotterdam, The Netherlands. The rationale and study design have been described previously.9 The medical ethics committee at the Erasmus University of Rotterdam approved the study, and written informed consent was obtained from all participants.
Abdominal ultrasonography was performed in the first 2 cohorts of the Rotterdam Study between February 2009
Results
FLI could be calculated in 3034 of 3205 elderly participants in whom liver ultrasonography was performed. In total, 382 participants were excluded for possible secondary causes of fatty liver (excessive alcohol consumption [n = 251], positive hepatitis B surface antigen or anti–hepatitis C virus [n = 21], and use of pharmacologic agents associated with fatty liver [n = 119]), leaving 2652 participants for analyses. General characteristics of the study population are shown in Table 1. Sixty
Discussion
In the present study we validated the FLI in 2652 elderly participants of the population-based Rotterdam Study. We demonstrated that FLI has good predictive values in elderly people for both ultrasonographically diagnosed fatty liver that is due to any cause as well as nonalcoholic fatty liver in this population, independent of age.
Sensitivity and specificity for fatty liver at the recommended cutoff of 60 (to rule in fatty liver) in the original study were 61% and 86%, respectively, and 62%
Acknowledgments
The authors thank the Rotterdam Study participants and Rotterdam Study team; in particular, they thank participating general practitioners and pharmacists.
References (19)
- et al.
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States
Gastroenterology
(2011) - et al.
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
J Hepatol
(2008) - et al.
The natural history of nonalcoholic fatty liver disease: a population-based cohort study
Gastroenterology
(2005) - et al.
Long-term follow-up of patients with nonalcoholic fatty liver
Clin Gastroenterol Hepatol
(2009) - et al.
Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study
J Hepatol
(2012) - et al.
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
BMJ
(2011) - et al.
Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population
Gastroenterology
(2009) - et al.
Serum aminotransferase activity and mortality risk in a United States community
Hepatology
(2008) - et al.
The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population
BMC Gastroenterol
(2006)
Cited by (222)
Changes in Fatty Liver Disease and Incident Diabetes Mellitus in Young Korean Adults
2024, American Journal of Preventive MedicineFatty Liver Change in Older Adults as an Important Risk Factor for Type 2 Diabetes: A Nationwide Cohort Study
2023, Mayo Clinic ProceedingsLiver integrity and the risk of Alzheimer's disease and related dementias
2024, Alzheimer's and Dementia
Conflicts of interest The authors disclose no conflicts.
Funding The Rotterdam Study is supported by the Erasmus MC University Medical Center and Erasmus University Rotterdam; the Netherlands Organization for Scientific Research (NWO); the Netherlands Organization for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the inistry of Education, Culture and Science; the Ministry of Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam.
This study was financially supported by the Foundation for Liver Research (SLO), Rotterdam, The Netherlands.